Fluorine 18 Market Scope And Analysis

  • Report Code : TIPRE00038973
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Fluorine-18 Market Analysis, Scope, and Growth by 2030

Buy Now

Fluorine-18 Market Report Fluorine-18 Market Size and Share Fluorine-18 Market Scope and Analysis

Fluorine-18 Market Report Scope

Report Attribute Details
Market size in 2022 US$ 1.72 Billion
Market Size by 2030 US$ 2.41 Billion
Global CAGR (2022 - 2030) 4.3%
Historical Data 2020-2022
Forecast period 2022-2030
Segments Covered By Product Type
  • FDG
  • NaF
By Application
  • Oncology
  • Cardiology
  • Neurology
By End User
  • Hospitals
  • Diagnostic Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Siemens Healthineers
  • Lantheus Medical Imaging Inc
  • Novartis AG
  • Cardinal Health
  • GE HealthCare
  • Jubilant Radiopharma
  • Eli Lilly and Company
  • Nukleon Nuclear Technology Research Ind Co Ltd
  • Curium Pharma

    • Competitive Landscape and Key Companies:

    Siemens Healthineers, Lantheus Medical Imaging Inc, Novartis AG, Cardinal Health, GE HealthCare, Jubilant Radiopharma, Eli Lilly and Company, Nukleon Nuclear Technology Research Ind Co Ltd, Curium Pharma, and Blue Earth Diagnostics Inc are among the prominent companies profiled in the fluorine-18 market report. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to meet the growing consumer demand worldwide.